Higher IP-10 serum levels can be observed in different liver pathologies, e.g. viral hepatitis B/C, PBC, biliary atresia and autoimmune liver disease with normalisation after treatment response [10, 11, 13, 23–25]. This evidence concerns the gene CXCL10 and hepatitis B virus infection.